EGFR and cancer: Toxic ·OH and low-dose doxycycline (DOX) are effective in synergistically inducing apoptosis of cancer cells and inhibiting EGFR and its downstream AKT/NF-κB/IκB signaling pathway, enhancing the effect of cancer treatment.